Handelsbanken Fonder AB - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 145 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2021$626,000
-6.8%
17,1000.0%0.00%
-25.0%
Q2 2021$672,000
+96.5%
17,100
+41.3%
0.00%
+100.0%
Q1 2021$342,000
-11.6%
12,1000.0%0.00%0.0%
Q4 2020$387,000
-1.0%
12,1000.0%0.00%
-33.3%
Q3 2020$391,000
-16.5%
12,100
-28.8%
0.00%
+50.0%
Q2 2020$468,00017,0000.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,684,118$84,523,00016.48%
Cederberg Capital Ltd 3,400,000$108,868,0002.00%
Capital International Sarl 570,500$18,267,0001.91%
AIA Group Ltd 437,118$14,971,0001.72%
Capital International, Inc./CA/ 4,711,405$150,859,0001.40%
M&G INVESTMENT MANAGEMENT LTD 3,096,345$99,083,0000.62%
Bellevue Group AG 947,674$30,345,0000.35%
Sands Capital Management 7,051,916$225,802,0000.22%
E Fund Management (Hong Kong) Co., Ltd. 18,836$603,0000.21%
Hudson Bay Capital Management LP 1,031,212$33,020,0000.18%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders